Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study
This cross-sectional study assessed the ability of ChatGPT-4, ChatGPT-3.5, and Google Bard to answer questions related to immuno-oncology.
This cross-sectional study assessed the ability of ChatGPT-4, ChatGPT-3.5, and Google Bard to answer questions related to immuno-oncology.
This scoping review identified all published outbreaks of vaccine preventable diseases in health care workers between 2000 and 2022. Vaccine preventable di
🌟 Join Our Team at Fox Chase – Temple Urologic Institute 🌟 Position: PHYSICIAN ASSISTANT (FT; 40hrs/wk) – Urology / Urologic Oncology at Jeanes Hospital…
8,428 likes, 434 comments – vinicius_kaiser on May 7, 2024: “Reclama agora do Exército!! 😂♥️”.
Anaplastic large cell lymphoma (ALCL) is an uncommon type of non-Hodgkin’s lymphoma (NHL), as well as one of the subtypes of T cell lymphoma, accounting…
AbstractBackground:. Sapanisertib (CB-228/TAK-228) is a potent, selective ATP-competitive, dual inhibitor of mTORC1/2. Metformin is thought to inhibit the mTOR pathway through upstream activation of 5′-AMP-activated…
Novel tissue-agnostic therapeutics targeting driver mutations in tumor cells have been recently approved by FDA, driven by basket trials that have demonstrated their efficacy and…
PURPOSE Human epidermal growth factor receptor 2 (HER2) is an effective therapeutic target in breast and gastric and gastroesophageal junction cancers. However, less is known…
PURPOSE To study whether BRAF V600 mutations in non–small-cell lung cancer (NSCLC) may indicate sensitivity to the BRAF inhibitor vemurafenib, we included a cohort of…
Purpose Parallel activation of the phosphatidylinositol 3-kinase–mammalian target of rapamycin pathway represents a mechanism of primary and acquired resistance to BRAF-targeted therapy, but the two…